GC Genome Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	35,118	6,528	3,637	13,637	10,743
Short-Term Investments	5,000	-	5,000	4,000	15,000
Cash & Short-Term Investments	40,118	6,528	8,637	17,637	25,743
Cash Growth	514.60%	-24.42%	-51.03%	-31.49%	-12.45%
Accounts Receivable	6,996	5,439	4,307	4,221	3,702
Other Receivables	1,336	12.94	65.78	325.42	71
Receivables	8,332	5,452	4,373	4,546	3,773
Inventory	1,997	1,219	1,152	1,200	598.2
Prepaid Expenses	373.86	371.57	292.15	697.09	126.16
Other Current Assets	149.05	93.33	96.29	40.37	30.69
Total Current Assets	50,970	13,663	14,550	24,120	30,271
Property, Plant & Equipment	12,254	14,918	18,759	18,094	8,293
Long-Term Investments	17,381	7,823	6,103	3,231	1,648
Other Intangible Assets	528.85	526.09	533.37	577.52	617.6
Long-Term Accounts Receivable	-0	0	-0	0	0
Long-Term Deferred Tax Assets	857.03	634.11	680.04	163.81	-
Other Long-Term Assets	2,635	3,058	2,194	2,709	1,601
Total Assets	84,627	40,622	42,819	48,896	42,431
Accounts Payable	-	-	851.58	1,311	1,293
Accrued Expenses	542.25	383.28	840.06	1,830	1,185
Short-Term Debt	-	-	6,556	-	-
Current Portion of Leases	833.8	792.17	802.31	997.42	685.06
Current Income Taxes Payable	220.89	-	-	-	-
Current Unearned Revenue	662.1	1,503	941.6	1,218	1,065
Other Current Liabilities	482.23	521.2	2,986	5,036	485.16
Total Current Liabilities	2,741	3,199	12,978	10,393	4,714
Long-Term Debt	-	-	-	5,819	12,913
Long-Term Leases	3,185	3,878	4,398	3,787	508.18
Long-Term Deferred Tax Liabilities	-	-	-	-	9
Other Long-Term Liabilities	428.26	465.2	395.84	2,312	5,320
Total Liabilities	6,354	7,543	17,772	22,311	23,464
Common Stock	11,825	9,778	9,067	9,067	8,000
Additional Paid-In Capital	68,841	29,865	21,036	21,010	10,475
Retained Earnings	-1,146	-5,281	-3,964	-3,244	491.96
Comprehensive Income & Other	-1,248	-1,282	-1,091	-247.95	-
Shareholders' Equity	78,273	33,080	25,048	26,585	18,967
Total Liabilities & Equity	84,627	40,622	42,819	48,896	42,431
Total Debt	4,018	4,670	11,757	10,604	14,106
Net Cash (Debt)	36,099	1,857	-3,120	7,033	11,636
Net Cash Growth	1843.62%	-	-	-39.56%	-31.71%
Net Cash Per Share	1651.29	101.96	-170.15	435.45	727.46
Filing Date Shares Outstanding	23.47	18.22	18.34	16.15	16
Total Common Shares Outstanding	23.47	18.22	18.34	16.15	16
Working Capital	48,229	10,464	1,572	13,728	25,557
Book Value Per Share	3335.23	1815.96	1366.01	1646.07	1185.74
Tangible Book Value	77,744	32,554	24,514	26,008	18,349
Tangible Book Value Per Share	3312.70	1787.08	1336.92	1610.31	1147.13
Buildings	6,914	7,142	7,727	6,810	1,111
Machinery	12,650	12,814	13,055	11,332	9,800
Construction In Progress	-	-	-	77.14	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.